Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Inhibrx Biosciences | INBX | Dec 27, 2024 | 15.01 | +0.47 |
InMed Pharmaceuticals | INM | Dec 27, 2024 | 4.74 | +3.27 |
InMode | INMD | Dec 27, 2024 | 17.02 | -1.62 |
INmune Bio | INMB | Dec 27, 2024 | 4.65 | -1.69 |
Innate Pharma ADR | IPHA | Dec 27, 2024 | 2.11 | +0.04 |
Inno Holdings | INHD | Dec 27, 2024 | 5.04 | +1.61 |
Innodata | INOD | Dec 27, 2024 | 45.36 | -1.88 |
Innospec | IOSP | Dec 27, 2024 | 110.66 | -0.83 |
InnovAge | INNV | Dec 27, 2024 | 3.92 | -3.21 |
Innovate | VATE | Dec 27, 2024 | 5.33 | -1.11 |
Innovation Beverage Group | IBG | Dec 27, 2024 | 1.14 | 0.00 |
Innovative Eyewear | LUCY | Dec 27, 2024 | 5.02 | -10.99 |
Innovative Industrial Properties | IIPR | Dec 27, 2024 | 68.11 | -3.68 |
Innovative Industrial Properties A Pref | IIPR-A | Dec 27, 2024 | 25.23 | +0.12 |
Innovative Solutions and Support | ISSC | Dec 27, 2024 | 8.75 | 0.00 |
Innovex International | INVX | Dec 27, 2024 | 13.56 | +1.19 |
Innovid | CTV | Dec 27, 2024 | 3.09 | -0.64 |
Innoviva | INVA | Dec 27, 2024 | 17.55 | -0.57 |
Innoviz Technologies | INVZ | Dec 27, 2024 | 1.80 | +0.56 |
InnSuites Hospitality | IHT | Dec 27, 2024 | 2.21 | -2.43 |
Innventure | INV | Dec 27, 2024 | 13.38 | 0.00 |
Inogen | INGN | Dec 27, 2024 | 8.58 | -0.23 |
Inotiv | NOTV | Dec 27, 2024 | 4.75 | -2.27 |
Inovio Pharmaceuticals | INO | Dec 27, 2024 | 1.87 | +0.54 |
Inozyme Pharma | INZY | Dec 27, 2024 | 2.92 | -4.26 |
Inpixon | XTIA | Dec 27, 2024 | 0.04 | -1.25 |
InPoint Commercial Real Estate Pref A | ICR-A | Dec 27, 2024 | 19.84 | -0.81 |
Inseego | INSG | Dec 27, 2024 | 10.41 | -3.25 |
Insight Enterprises | NSIT | Dec 27, 2024 | 152.09 | -1.72 |
Insight Select Income Fund | INSI | Dec 27, 2024 | 16.67 | -1.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.